| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/20/2006 | CA2583333A1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2583114A1 Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and method of making them |
| 04/20/2006 | CA2583101A1 Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline |
| 04/20/2006 | CA2583017A1 Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease |
| 04/20/2006 | CA2582593A1 Cgrp receptor antagonists |
| 04/20/2006 | CA2581918A1 Imidazo(1,5-a)triazolo(1,5-d) benzodiazepine deratives for the treatment of cognitive disorders |
| 04/20/2006 | CA2581188A1 Treatment of bipolar disorders and associated symptoms |
| 04/19/2006 | EP1647555A1 The c-glycosylisoflavones having alkylaminoalkoxyl substituent, the preparation and the use of the same |
| 04/19/2006 | EP1647280A2 Composition for promoting development of nervous system |
| 04/19/2006 | EP1647275A1 Solid pharmaceutical preparation |
| 04/19/2006 | EP1647272A1 Curing and prophylactic agent applied during the use of alcohol and psychoactive substances |
| 04/19/2006 | EP1646626A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 04/19/2006 | EP1646625A1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 04/19/2006 | EP1646622A1 Tacrine derivatives as inhibitors of acetylcholinesterase |
| 04/19/2006 | EP1646621A2 Novel azaheterocyclic amides useful for treating pain |
| 04/19/2006 | EP1646620A1 Substituted piperidines as histamine h3 receptor ligands |
| 04/19/2006 | EP1646393A1 A stable clozapine suspension formulation |
| 04/19/2006 | EP1646391A1 Use of 2h-[1,3]-oxazino[3,2-a]indole derivatives for the treatment of neuropathic pain |
| 04/19/2006 | EP1646390A1 A1 adenosine receptor antagonists |
| 04/19/2006 | EP1646387A1 Use of indazole derivatives for the treatment of neuropathic pain |
| 04/19/2006 | EP1646386A2 Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor |
| 04/19/2006 | EP1646379A2 Novel solid pharmaceutical composition comprising amisulpride |
| 04/19/2006 | EP1646377A2 Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator |
| 04/19/2006 | EP1646375A2 Treatment of protein aggregation disorders |
| 04/19/2006 | EP1646328A2 Treatment of dependence withdrawal |
| 04/19/2006 | EP1534711B1 Phenyl-substituted pyrazolopyrimidines |
| 04/19/2006 | EP1521523A4 Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues |
| 04/19/2006 | EP1487801B1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo¬d|azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders |
| 04/19/2006 | EP1472236A4 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |
| 04/19/2006 | EP1409001B1 Mineral-protein preparations (mpp) and neuropathies in diabetes |
| 04/19/2006 | EP1401439B1 Use of bicyclo compounds for treating alzheimer's disease |
| 04/19/2006 | EP1387838B1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 04/19/2006 | EP1370559B1 Triazolopyridines as anti-inflammatory agents |
| 04/19/2006 | EP1368016B1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt |
| 04/19/2006 | EP1339706B1 N-type calcium channel antagonists for the treatment of pain |
| 04/19/2006 | EP1317428B1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 04/19/2006 | EP1299102B1 Use of riluzole or its salts for preventing and treating adrenoleukodystrophy |
| 04/19/2006 | EP1296692B1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1292187B1 Transgenic animal model of neurodegenerative disorders |
| 04/19/2006 | EP1237886B1 Meglumine salt of a specific quinolinecarboxylic acid compound active on nmda receptors |
| 04/19/2006 | EP1196167B1 Use of p38 MAPK inhibitors in the treatment of ophthalmic conditions |
| 04/19/2006 | EP1126853B1 Controlled delivery of antidepressants |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | EP1041987B1 Pharmaceutical oral dosage form comprising a combination of an opioid agonist and naltrexone |
| 04/19/2006 | EP0901474B1 Aryl pyrimidine derivatives |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | CN1761680A Metastin derivative and use thereof |
| 04/19/2006 | CN1761657A EP4 receptor antagonists |
| 04/19/2006 | CN1761467A Use of pyridin-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin |
| 04/19/2006 | CN1761464A Substituted p-diaminobenzene derivatives |
| 04/19/2006 | CN1761452A Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 04/19/2006 | CN1760205A Mutant of ciliary nerves trophic factor (CNTF), producing method and usage |
| 04/19/2006 | CN1760183A New brand of Aripipazole, and preparation method |
| 04/19/2006 | CN1759888A Application scheme for treating injury of spinal cord by transplanting Olfactory essheathing cells |
| 04/19/2006 | CN1759865A Medicinal granules of kudzuvine root, mint, an dprpearation technique |
| 04/19/2006 | CN1759863A Recipe of drop pills of corydalis and its preparation method |
| 04/19/2006 | CN1759846A Antidotal chewing gum of Chinese traditional medicine |
| 04/19/2006 | CN1759843A Application of astragaloside in preparing medication for treating peripheral nervous lesion of diabetes |
| 04/19/2006 | CN1759836A Sublingual tablet of keeping in mouth of Donepezil and derivatives |
| 04/19/2006 | CN1759831A Application of phenchlobenpyrrone |
| 04/19/2006 | CN1759830A Enteric coated table of duloxetine, and preparation method |
| 04/19/2006 | CN1759829A Duloxetine enteric coated tiny pill capsule, and preparation method |
| 04/19/2006 | CN1252070C Urea substituted imidazoquinolines |
| 04/19/2006 | CN1252068C Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1 |
| 04/19/2006 | CN1252067C Benzazole derivatives and their use as JNK modulators |
| 04/19/2006 | CN1252058C Phenoxy indenone compounds, process for preparing same and use thereof |
| 04/19/2006 | CN1252057C Thiazole derivatives for treating PPAR related disorders |
| 04/19/2006 | CN1251758C Use of derivatives of valproic acid and 2-valproenic acid amides for treatment of mania in bipolar disorder |
| 04/19/2006 | CN1251739C Chinese medicine preparation for treating neruosia |
| 04/19/2006 | CN1251734C Sobering and liver protecting liquid product and its production method |
| 04/19/2006 | CN1251731C Chinese herbal medicine for treating intractable headache |
| 04/19/2006 | CN1251727C Traditional Chinese medicine for treating headache disease |
| 04/19/2006 | CN1251695C Pharmaceutical composition containing elegiline and ginkgo bioloba extract useful for dementia |
| 04/19/2006 | CN1251689C Veal-blood protein-removed extract infusion and its preparation process |
| 04/19/2006 | CN1251671C Beta secretase inhibitors |
| 04/18/2006 | US7030252 Cyanation by converting the 5-formyl compound with hydroxylamine, dehydration to form antidepressant agents; chemical synthesis, salt formation, forming enantiomers; serotonin reuptake inhibitors for treating dementia and cerebrovascular disorders |
| 04/18/2006 | US7030245 A chemical intermediate, toluene-4-sulfonic acid 7,8-dihydro-6H-5-oxa-1-aza-phenanthren-6-ylmethyl ester for preparing antidepressant, 6-[4-(5-fluoro-1H-indol-3-yl)-3,6-dihydro-2H-pyridin-1-ylmethyl]-7,8-dihydro-6H-5-oxa-1aza-phenanthrene; treating psychological disorders |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030240 Piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 04/18/2006 | US7030239 Compounds to treat Alzheimer's disease |
| 04/18/2006 | US7030164 This invention relates to a highly thermally stable novel anhydrous crystalline polymorphic form of venlafaxine hydrochloride, methods for the preparation thereof, and its use. |
| 04/18/2006 | US7030162 Storage stabilized dosage |
| 04/18/2006 | US7030160 An agonist as beta-3 adrenergic receptors; chemical intermediates preparing through decyclization, hydroxylation; for treating gastrointestinal diseases, obesity, diabetics, psychotropic agents, nervous system disorders |
| 04/18/2006 | US7030144 Central nervous system disorders |
| 04/18/2006 | US7030139 Compounds |
| 04/18/2006 | US7030136 Administering phanquinone to the subject, optionally together with one or more pharmaceutically acceptable carriers for improving the learning or memory of a normal subject |
| 04/18/2006 | US7030135 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 04/18/2006 | US7030133 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 04/18/2006 | US7030128 Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 04/18/2006 | US7030126 Use of polyamine analogs for amyotrophic lateral sclerosis |
| 04/18/2006 | US7030124 Method of treating depression with delta receptor agonist compounds |
| 04/18/2006 | US7030121 Pyrazolopyrazine compound and pharmaceutical use thereof |
| 04/18/2006 | US7030108 Administering to patient effective amount of neurotransmission modulating composition comprising 5HT antagonist and/or alpha 2 antagonist |
| 04/18/2006 | US7030107 nitrogen compounds such as 5-[3,5-bis(trifluoromethyl)benzyl]-6-oxo-7-phenyl-9-[4-(pyrrolidine-1-yl)piperidine-1-yl]-2,3,4,5-tetrahydro-6H-pyrido[2,3-b][1,5]oxazocine, used as neurokinin inhibitors for prophylaxis of urogenital disorders; side effect reduction |
| 04/18/2006 | US7030100 Analgesic inhibitor of isoforms of cyclic guanosine monophosphate (cGMP)-dependent protein kinase I alpha (PKGI alpha); drug screening |
| 04/18/2006 | US7030090 Immune-modulating peptide |
| 04/18/2006 | US7030086 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/18/2006 | US7030081 Muteins of the Ser-Cys-Asn-Thr-Ala-Thr-Cys sequence from the N- terminal 1-7 fragment of the CGRP (calcitonin gene related peptide), activates neuronal nicotinic receptor, therefor useful for therapy of neurological disorders |